Influence of candidate polymorphisms on the dipeptidyl peptidase IV and μ-opioid receptor genes expression in aspect of the β-casomorphin-7 modulation functions in autism

Peptides

Volumn 65, Issue , 2015, Pages 6-11

  Cies̈lińska, Anna ^a   Sienkiewicz Szłapka, Edyta ^a   Wasilewska, Jolanta ^b   Fiedorowicz, Ewa ^a   Chwała, Barbara ^c   Moszyńska Dumara, Małgorzata ^c   Cies̈liński, Tomasz ^c   Bukało, Marta ^a   Kostyra, Elzbieta ^a  

^a UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^c Provincial Specialist Hospital in Olsztyn   (Poland)

Author keywords

ASD; Autism; Dipeptidyl peptidase IV; Gene polymorphism; Casomorphin 7; Opioid receptor

Indexed keywords

BETA CASOMORPHINE; BETA CASOMORPHINE 7; BETA-CASOMORPHIN 7; DIPEPTIDYL PEPTIDASE IV; DPP4 PROTEIN, HUMAN; DRUG ADMINISTRATION; ENDORPHIN; MILK PROTEIN; MU OPIATE RECEPTOR; OPRM1 PROTEIN, HUMAN; PEPTIDE FRAGMENT; PROTEIN HYDROLYSATE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLELE; ANIMAL; ARTICLE; AUTISM; BOVINE; BRAIN FUNCTION; CASE CONTROL STUDY; CHEMISTRY; CHILD; COMPULSION; CONTROLLED STUDY; CORRELATIONAL STUDY; DIPEPTIDYL PEPTIDASE IV GENE; DNA POLYMORPHISM; FEMALE; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETICS; GENOTYPE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METABOLISM; MILK; MU OPIOID RECEPTOR GENE; NEUROMODULATION; PATHOPHYSIOLOGY; POINT MUTATION; POLAND; PRESCHOOL CHILD; PRIORITY JOURNAL; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADMINISTRATION AND DOSAGE; ADOLESCENT; ALLELES; ANIMALS; AUTISTIC DISORDER; CASE-CONTROL STUDIES; CATTLE; CHEMISTRY; CHILD; CHILD, PRESCHOOL; DIPEPTIDYL PEPTIDASE 4; ENDORPHINS; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETICS; GENOTYPE; HUMANS; MALE; METABOLISM; MILK PROTEINS; PEPTIDE FRAGMENTS; PHYSIOPATHOLOGY; POLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN HYDROLYSATES; RECEPTORS, OPIOID, MU; YOUNG ADULT;

EID: 84964203397     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2014.11.012     Document Type: Article

References (54)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 4th ed. 2000 American Psychiatric Association Washington, DC
2. C. Bond, K.S. LaForge, M. Tian, D. Melia, S. Zhang, and L. Borg Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: possible implications for opiate addiction PNAS 95 16 1998 9608 9613
3. T. Buie The relationship of autism and gluten Clin Ther 35 5 2013 578 583
4. G. Campana, D. Sarti, S. Spampinato, and W. Raffaeli Long-term intrathecal morphine and bupivacaine upregulate MOR gene expression in lymphocytes Int Immunopharmacol 10 2010 1149 1152
5. A. Cies̈lińska, E. Kostyra, H. Kostyra, K. Oleński, E. Fiedorowicz, and S. Kamiński Milk from cows of different β-casein genotypes as a source of β-casomorphin-7 Int J Food Sci Nutr 63 4 2012 426 430
6. B. Čupić, D. Hranilovic, B. Jernej, and J. Gabrilovac Association study of genes regulating opioid system in autism Psychiatry Res 198 1 2012 169 170
7. J.H. Elder Autism and the gluten-free, casein-free (GFCF) diet Fam Health 10 2013 08
8. E. Fiedorowicz, B. Jarmołowska, M. Iwan, E. Kostyra, R. Obuchowicz, and M. Obuchowicz The influence of μ-opioid receptor agonist and antagonist peptides on peripheral blood mononuclear cells (PBMCs) Peptides 32 4 2011 707 712
9. E. Fiedorowicz, M. Kaczmarski, A. Cies̈lińska, E. Sienkiewicz-Szłapka, B. Jarmołowska, B. Chwała, and E. Kostyra β-Casomorphin-7 alters μ-opioid receptor and dipeptidyl peptidase IV genes expression in children with atopic dermatitis Peptides 62 2014 144 149
10. R.B. Fillingim, L. Kaplan, R. Staud, T.J. Ness, T.L. Glover, and C.M. Campbell The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans J Pain 6 3 2005 159 167
11. B.M. Flashner, M.E. Russo, J.E. Boileau, D.W. Leong, and G.I. Gallicano Epigenetic factors and autism spectrum disorders Neuromol Med 15 2 2013 339 350
12. E. Fombonne Epidemiology of pervasive developmental disorders Pediatr Res 65 2009 591 598
13. C. Giulivi, Y.F. Zhang, A. Omanska-Klusek, C. Ross-Inta, S. Wong, and I. Hertz-Picciotto Mitochondrial dysfunction in autism JAMA 304 21 2010 2389 2396
14. P. Goines, and J. Van de Water The immune system's role in the biology of autism Curr Opin Neurol 23 2 2010 111
15. R.J. Goody, and I. Kitchen Influence of maternal milk on functional activation of δ-opioid receptors in postnatal rats J Pharmacol Exp Ther 296 3 2001 744 748
16. D. Grafodatskaya, B. Chung, P. Szatmari, and R. Weksberg Autism spectrum disorders and epigenetics J Am Acad Child Adolesc Psychiatry 49 8 2010 794 809
17. A. Guareschi Cazzull, M.C. Musetti, L. Musetti, S. Bajo, P. Sacerdote, and A. Panerai β-Endorphin levels in peripheral blood mononuclear cells and long-term naltrexone treatment in autistic children Eur Neuropsychopharmacol 9 4 1999 361 366
18. P. Haggarty Epigenetic consequences of a changing human diet Proc Nutr Soc 72 04 2013 363 371
19. L. Hall, and E. Kelley The contribution of epigenetics to understanding genetic factors in autism Autism 2013 10.1177/1362361313503501
20. J. Hallmayer, S. Cleveland, A. Torres, J. Phillips, B. Cohen, and Torigoe Genetic heritability and shared environmental factors among twin pairs with autism Arch Gen Psychiatry 68 11 2011 1095 1102
21. M.R.U. Haq, R. Kapila, R. Sharma, V. Saliganti, and S. Kapila Comparative evaluation of cow β-casein variants (A1/A2) consumption on Th2-mediated inflammatory response in mouse gut Eur J Nutr 53 2014 1039 1049
22. L.C. Hunter, A. O'Hare, W.J. Herron, L.A. Fisher, and G.E. Jones Opioid peptides and dipeptidyl peptidase in autism Dev Med Child Neurol 45 2 2003 121 128
23. B. Jarmołowska, K. Bielikowicz, M. Iwan, K. Sidor, E. Kostyra, and M. Kaczmarski Serum activity of dipeptidylpeptidase IV (DPPIV; EC 3.4.14.5) in breast-fed infants with symptoms of allergy Peptides 28 2007 678 682
24. M. Kaczmarski, J. Wasilewska, and M. Lasota Hypersensitivity to hydrolyzed cow's milk protein formula in infants and young children with atopic eczema/dermatitis syndrome with cow's milk protein allergy Ann Acad Med Bialostoc 50 2005 274 278
25. B.L. Kieffer, and C. Gavériaux-Ruff Exploring the opioid system by gene knockout Prog Neurobiol 66 5 2002 285 306
26. P. Klepstad, T.T. Rakvåg, S. Kaasa, M. Holthe, O. Dale, and P.C. Borchgrevink The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease Acta Anaesth Scand 48 10 2004 1232 1239
27. E. Kostyra, E. Sienkiewicz-Szłapka, B. Jarmołowska, S. Krawczuk, and H. Kostyra Opioid peptides derived from milk proteins Pol J Food Nutr Sci 13/54 1 2004 25 35
28. I.M. Lacroix, and E.C. Li-Chan Investigation of the putative associations between dairy consumption and incidence of type 1 and type 2 diabetes Crit Rev Food Sci 54 4 2014 411 432
29. K.S. LaForge, V. Shick, R. Spangler, D. Proudnikov, V. Yuferov, and Y. Lysov Detection of single nucleotide polymorphisms of the human mu opioid receptor gene by hybridization or single nucleotide extension on custom oligonucleotide gelpad microchips: potential in studies of addiction Am J Med Genet 96 5 2000 604 615
30. L.H. Lindstrom, F. Nyberg, L. Terenius, K. Bauer, G. Besev, and L.M. Gunne CSF and plasma beta-casomorphin-like opioid peptides in post-partum psychosis Am J Psychiatry 141 1984 1059 1066
31. P. Mayer, and V. Höllt Allelic and somatic variations in the endogenous opioid system of humans Pharmacol Ther 91 3 2001 167 177
32. P. Nowotny, J.M. Kwon, and A.M. Goate SNP analysis to dissect human traits Curr Opin Neurol 11 2001 637 641
33. M.W. Pfaffl Live stock transcriptomics: quantitative mRNA analytics in molecular endocrinology and physiology 2003 Technische Universitat Munchen Weihenstephan
34. K.L. Reichelt, A.M. Knivsberg, G. Lind, and M. Nodland Probable aetiology and possible treatment of childhood autism Brain Dysfunct 4 1991 308 319
35. R.R. Romberg, E. Olofsen, H. Bijl, P.E. Taschner, L.J. Teppema, and E.Y. Sarton Polymorphism of mu-opioid receptor gene (OPRM1:c.118A > G) does not protect against opioid-induced respiratory depression despite reduced analgesic response Anesthesiology 102 3 2005 522 530
36. H. Schellekens, A.B. Nongonierma, G. Clarke, W.E. van Oeffelen, R.J. FitzGerald, and T. Dinan Milk protein-derived peptides induce 5-HT < sub > 2C < /sub > -mediated satiety in vivo Int Dairy J 38 1 2014 55 64
37. S.A. Shabalina, D.V. Zaykin, P. Gris, A.Y. Ogurtsov, J. Gauthier, and K. Shibata Expansion of the human mu-opioid receptor gene architecture: novel functional variants Hum Mol Genet 18 6 2009 1037 1051
38. J.J. Shah, M. Trivedi, N. Hodgson, and R. Deth Casein and gluten-derived opiate peptides affect cysteine uptake and redox status FASEB J 27 2013 1075 1081
39. L. Sher Autistic disorder and the endogenous opioid system Med Hypotheses 48 1997 413 414
40. K. Sidor, B. Jarmołowska, M. Kaczmarski, E. Kostyra, M. Iwan, and H. Kostyra Content of β-casomorphins in milk of women with a history of allergy Pediatr Allergy Immunol 19 7 2008 587 591
41. O.Y. Sokolov, N.V. Kost, Y.A. Zolotarev, E.N. Ryukert, and A.A. Zozulya Influence of human beta-casomorphin-7 on specific binding of 3H-spiperone to the 5-HT2-receptors of rat brain frontal cortex Prot Pept Lett 13 2006 169 170
42. O. Sokolov, N. Kost, O. Andreeva, E. Korneeva, V. Meshavkin, and Y. Tarakanova Autistic children display elevated urine levels of bovine casomorphin-7 immunoreactivity Peptides 56 2014 68 71
43. Z. Sun, and J.R. Cade A peptide found in schizophrenia and autism causes behavioral changes in rats Autism 3 1 1999 85 95
44. Z. Sun, Z. Zhang, X. Wang, R. Cade, and Z. Elmir Relation of beta-casomorphins to apnea in sudden infant death syndrome Peptides 24 2003 937 943
45. H. Teschemacher Opioid receptor ligands derived from food proteins Curr Pharm Des 9 16 2003 1331 1344
46. C. Tiruppathi, V. Ganapathy, and F.H. Leibach Evidence for tripeptide-proton symport in renal brush border membrane vesicles. Studies in a novel rat strain with a genetic absence of dipeptidyl peptidase IV J Biol Chem 265 4 1990 2048 2053
47. S. Tordjman, G.M. Anderson, M. Botbol, S. Brailly-Tabard, F. Perez-Diaz, and R. Graignic Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder PLoS ONE 4 8 2009 e5289
48. D. Tveiten, A. Finvold, M. Andersson, and K.L. Reichelt Peptides and exorphins in the autism spectrum O J Psych 4 2014 275 287
49. R.J. Wallace, and N. McKain Peptidase activity of human colonic bacteria Anaerobe 3 1997 251 257
50. J. Wasilewska, E. Jarocka-Cyrta, and M. Kaczmarski The pathogenesis of gastrointestinal disorders in children with autism Pol Merkur Lek 27 2009 40 43
51. J. Wasilewska, M. Kaczmarski, E. Kostyra, and M. Iwan Cow's-milk-induced infant apnoea with increased serum content of bovine β-casomorphin-5 JPGN 52 6 2011 772 775
52. J. Wasilewska, E. Sienkiewicz-Szłapka, E. Kuźbida, B. Jarmołowska, M. Kaczmarski, and E. Kostyra The exogenous opioid peptides and DPPIV serum activity in infants with apnoea expressed as apparent life threatening events (ALTE) Neuropeptides 45 2011 189 195
53. P. Whiteley, and P. Shattock Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention Expert Opin Ther Targets 6 2 2002 175 183
54. Y. Zhang, D. Wang, A.D. Johnson, A.C. Papp, and W. Sadée Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G J Biol Chem 280 38 2005 32618 32624